🔗 Share this article

While the United States continues making sweeping changes to its vaccine schedules, an unexpected name appears somewhat surprisingly: Tracy Beth Høeg, an American of Danish descent sports medicine doctor and public health researcher who first made her name by casting doubt on COVID-19 shots in the pandemic and has concentrated on alleged fatalities after COVID-19 vaccination in her short position at the Food and Drug Administration.

Proposed Shifts to Childhood Immunization Program

Health officials were set to announce sweeping changes to the pediatric vaccination calendar recently, synchronizing the US with Denmark’s immunization schedule, it is understood – a significant shift that would put the US out of alignment with a large portion of the world with insufficient data for benefit. The planned update has been postponed until the coming year.

In place of the top vaccines chief, Høeg is set to address the audience at the meeting. She was recently named interim head of the FDA’s CDER, the fifth person to head the center this year.

A Shift at the Regulatory Body

This interim role may indicate a strengthened alliance between the drug and vaccine divisions as Høeg and Dr. Prasad solidify control at the regulatory agency – and it points to a renewed priority upon rolling back already-approved immunizations at the FDA.

Dr. Høeg has repeatedly called for discontinuing certain childhood immunization guidelines in the US in order to be more like Denmark's approach, a society with comprehensive healthcare and a citizenry about the size of Wisconsin’s.

In her initial statements, she has kept her attention on vaccines – traditionally the responsibility of Dr. Prasad, director of the FDA’s vaccine center – instead of drug regulation.

Questions Over Background

Høeg has little discernible experience in drug development, oversight or leadership, which has been customary for former directors of the biologics center. She has worked at the FDA as a top consultant to the agency head and the vaccine center since March.

“It seems she lacks to have the requisite experience” for leading the CDER, stated a neurologist and psychiatrist. “She lacks experience running a clinical trial. She lacks experience in managing a large organization. She has no expertise in drug approvals.”

Previous heads of the center would “grasp regulatory frameworks and the underlying principles of medication creation”, said Janet Woodcock. “Objectively, she lacks the sort of resume that former directors who ran the center have had.”

This division has an immense workload at the agency, she pointed out.

“Everybody just zeroes in on the innovative therapies, but the off-patent medication office authorizes numerous generic medications. There is also a biosimilars division, over-the-counter program and more, and every single one need to be looked after,” Woodcock said. “The area you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Furthermore, a significant administrative component to the job, which manages more than 5,000 staff members. “It’s a huge leadership role, if you do it right,” she added.

Response and Controversial Programs

In response to inquiries about Høeg’s fitness for the role and whether this appointment indicates greater collaboration among agency officials on vaccines, a press secretary responded that the “concerns are based on flawed assumptions”.

“Her experience is consistent with the functions of her position,” the representative said, citing the time Dr. Høeg spent advising the FDA commissioner on “pharmaceutical safety and regulatory science, including predictive safety algorithms and vaccine surveillance”.

As the temporary head, Dr. Høeg takes over the commissioner’s recently launched expedited review system, a disputed one-day therapy clearance system that reportedly troubled her preceding directors. “How are these therapies being chosen for this fast-track system? Who takes the calls?” Howard said. “There’s a lot of secrecy happening at the agency right now.”

Broadly speaking, he said, “the agency appears to be shifting towards less stringent rules of most medications, aside from immunizations.”

Documented Past Work on Vaccines

Concerning immunizations, Dr. Høeg has a more established, if troubling, past, Howard observe. She published a analysis using unverified crowd-sourced reports to determine the incidence of heart inflammation after COVID-19 immunization. She counseled the state of Florida chief medical officer Joseph Ladapo, who allegedly have modified findings to suggest COVID-19 vaccinations are riskier than they are.

Included in her “policy goals” for the current government encompassed altering guidelines for recently developed shots and ending “non-essential” immunizations, she said following the vote on a online show. At the agency, Dr. Høeg has reportedly suggested preventing adolescent males from getting Covid vaccines.

“She’s an all-around true believer who commences with her beliefs and works backwards to accommodate the data in a extremely misleading, dishonest manner,” Dr. Howard said.

Taking Control and a “Campaign of Retribution”

Høeg joined fellow dissenters, {like|